These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16541167)

  • 1. [Lox-1--an actor in cardiovascular disease?].
    Ranheim T; Halvorsen B
    Tidsskr Nor Laegeforen; 2006 Mar; 126(6):753-5. PubMed ID: 16541167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.
    Mehta JL
    Can J Cardiol; 2004 Aug; 20 Suppl B():32B-36B. PubMed ID: 15309203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
    Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
    Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?
    Chen XP; Zhang TT; Du GH
    Cardiovasc Drug Rev; 2007; 25(2):146-61. PubMed ID: 17614937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis].
    Morawietz H
    Dtsch Med Wochenschr; 2010 Feb; 135(7):308-12. PubMed ID: 20146162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lectin-like oxidized LDL receptor-1 as extracellular chaperone receptor: its versatile functions and human diseases.
    Inoue N; Sawamura T
    Methods; 2007 Nov; 43(3):218-22. PubMed ID: 17920518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis and the Lectin-like OXidized low-density lipoprotein scavenger receptor.
    Vohra RS; Murphy JE; Walker JH; Ponnambalam S; Homer-Vanniasinkam S
    Trends Cardiovasc Med; 2006 Feb; 16(2):60-4. PubMed ID: 16473764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells.
    Mehta JL; Chen J; Yu F; Li DY
    Cardiovasc Res; 2004 Nov; 64(2):243-9. PubMed ID: 15485683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice.
    Inoue K; Arai Y; Kurihara H; Kita T; Sawamura T
    Circ Res; 2005 Jul; 97(2):176-84. PubMed ID: 15961718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders.
    Mehta JL; Chen J; Hermonat PL; Romeo F; Novelli G
    Cardiovasc Res; 2006 Jan; 69(1):36-45. PubMed ID: 16324688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein-induced apoptosis in human umbilical vein endothelial cells: role of reactive oxygen species.
    Chen XP; Xun KL; Wu Q; Zhang TT; Shi JS; Du GH
    Vascul Pharmacol; 2007 Jul; 47(1):1-9. PubMed ID: 17433786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet.
    Hu C; Dandapat A; Sun L; Chen J; Marwali MR; Romeo F; Sawamura T; Mehta JL
    Cardiovasc Res; 2008 Jul; 79(2):287-93. PubMed ID: 18453637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in the development of hypertensive organ damage.
    Ando K; Fujita T
    Clin Exp Nephrol; 2004 Sep; 8(3):178-82. PubMed ID: 15480893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol-lowering drugs inhibit lectin-like oxidized low-density lipoprotein-1 receptor function by membrane raft disruption.
    Matarazzo S; Quitadamo MC; Mango R; Ciccone S; Novelli G; Biocca S
    Mol Pharmacol; 2012 Aug; 82(2):246-54. PubMed ID: 22570368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LOX-1 in atherosclerotic disease.
    Sawamura T; Wakabayashi I; Okamura T
    Clin Chim Acta; 2015 Feb; 440():157-63. PubMed ID: 25463747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment.
    Puccetti L; Pasqui AL; Bruni F; Pastorelli M; Ciani F; Palazzuoli A; Pontani A; Ghezzi A; Auteri A
    Int J Cardiol; 2007 Jun; 119(1):41-7. PubMed ID: 17050011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of cytoplasmic sequences for cell-surface sorting of the lectin-like oxidized LDL receptor-1 (LOX-1).
    Chen M; Sawamura T
    J Mol Cell Cardiol; 2005 Sep; 39(3):553-61. PubMed ID: 15935375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in atherogenesis and tumorigenesis.
    Lu J; Mitra S; Wang X; Khaidakov M; Mehta JL
    Antioxid Redox Signal; 2011 Oct; 15(8):2301-33. PubMed ID: 21338316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression and down stream effect of lectin like-oxidized low density lipoprotein 1 (LOX-1) in hyperglycemic state.
    Rudijanto A
    Acta Med Indones; 2007; 39(1):36-43. PubMed ID: 17939209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay.
    Chen X; Zhang T; Du G
    Cell Biochem Funct; 2008 Oct; 26(7):760-70. PubMed ID: 18636435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.